These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

935 related items for PubMed ID: 25934946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.
    Syková E, Rychmach P, Drahorádová I, Konrádová Š, Růžičková K, Voříšek I, Forostyak S, Homola A, Bojar M.
    Cell Transplant; 2017 Apr 13; 26(4):647-658. PubMed ID: 27938483
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
    Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, Melamed E, Karussis D.
    JAMA Neurol; 2016 Mar 13; 73(3):337-44. PubMed ID: 26751635
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.
    Oh KW, Noh MY, Kwon MS, Kim HY, Oh SI, Park J, Kim HJ, Ki CS, Kim SH.
    Ann Neurol; 2018 Sep 13; 84(3):361-373. PubMed ID: 30048006
    [Abstract] [Full Text] [Related]

  • 7. Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis.
    Siwek T, Jezierska-Woźniak K, Maksymowicz S, Barczewska M, Sowa M, Badowska W, Maksymowicz W.
    Med Sci Monit; 2020 Dec 10; 26():e927484. PubMed ID: 33301428
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study.
    Shamsaei G, Houshmand F, Ahmadzadeh Deylami A, Valizadeh A, Rafie S, Moradi M.
    Adv Pharm Bull; 2023 Mar 10; 13(2):361-367. PubMed ID: 37342380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial.
    Nabavi SM, Arab L, Jarooghi N, Bolurieh T, Abbasi F, Mardpour S, Azimyian V, Moeininia F, Maroufizadeh S, Sanjari L, Hosseini SE, Aghdami N.
    Cell J; 2019 Jan 10; 20(4):592-598. PubMed ID: 30124008
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis.
    Tavakol-Afshari J, Boroumand AR, Farkhad NK, Adhami Moghadam A, Sahab-Negah S, Gorji A.
    Regen Ther; 2021 Dec 10; 18():268-274. PubMed ID: 34466632
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
    Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, Bulte JW, Petrou P, Ben-Hur T, Abramsky O, Slavin S.
    Arch Neurol; 2010 Oct 10; 67(10):1187-94. PubMed ID: 20937945
    [Abstract] [Full Text] [Related]

  • 16. Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
    Baek W, Kim YS, Koh SH, Lim SW, Kim HY, Yi HJ, Kim H.
    J Neurosurg Sci; 2012 Sep 10; 56(3):261-3. PubMed ID: 22854595
    [Abstract] [Full Text] [Related]

  • 17. Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cells.
    Reis ALG, Maximino JR, Lage LAPC, Gomes HR, Pereira J, Brofman PRS, Senegaglia AC, Rebelatto CLK, Daga DR, Paiva WS, Chadi G.
    Stem Cell Res Ther; 2024 Sep 15; 15(1):301. PubMed ID: 39278909
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results.
    Gotkine M, Caraco Y, Lerner Y, Blotnick S, Wanounou M, Slutsky SG, Chebath J, Kuperstein G, Estrin E, Ben-Hur T, Hasson A, Molakandov K, Sonnenfeld T, Stark Y, Revel A, Revel M, Izrael M.
    J Transl Med; 2023 Feb 14; 21(1):122. PubMed ID: 36788520
    [Abstract] [Full Text] [Related]

  • 19. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis.
    Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Boccaletti R, Testa L, Livigni S, Fagioli F.
    Neurol Res; 2006 Jul 14; 28(5):523-6. PubMed ID: 16808883
    [Abstract] [Full Text] [Related]

  • 20. NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
    Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, Owegi M, Nicholson K, McKenna-Yasek D, Levy YS, Abramov N, Kaspi H, Mehra M, Aricha R, Gothelf Y, Brown RH.
    Neurology; 2019 Dec 10; 93(24):e2294-e2305. PubMed ID: 31740545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.